Bioprocess Containers Market Size, Share & Trends Analysis Report By Product (2D Bioprocess Containers, 3D Bioprocess Containers), By Application (Upstream Process, Downstream Process), By End Use, By Region, And Segment Forecasts, 2025 - 2033

Bioprocess Containers Market Growth & Trends

The global bioprocess containers market size is anticipated to reach USD 26.22 billion by 2033, registering a CAGR of 22.6% from 2025 to 2033, according to a new report by Grand View Research, Inc. The industry is experiencing significant growth, driven primarily by the rising demand for single-use technologies (SUT) in biopharmaceutical manufacturing. Traditional stainless-steel systems are being replaced by disposable bioprocess containers due to their cost efficiency, reduced risk of cross-contamination, and flexibility in production. For example, companies such as Thermo Fisher Scientific Inc. and Sartorius AG offer pre-sterilized, customizable bags that streamline processes in monoclonal antibody (mAb) and vaccine production. The shift toward single-use systems is particularly evident in cell and gene therapy manufacturing, where sterility and rapid turnaround times are critical.

Another key driver is the expansion of the biopharmaceutical industry, fueled by increasing investments in biologics and biosimilars. The global emphasis on personalized medicine and orphan drugs has led to smaller, more frequent batch productions, where bioprocess containers excel. For instance, Moderna and Pfizer-BioNTech relied heavily on single-use bioreactor bags for rapid COVID-19 vaccine scale-up. Additionally, emerging markets in Asia-Pacific, countries such as China and India, are witnessing growth due to government incentives for local biomanufacturing, further boosting demand for disposable containers.

Regulatory support and technological advancements are also propelling market growth. Regulatory agencies such as the FDA and EMA have endorsed single-use systems, emphasizing their role in reducing contamination risks. Innovations such as 3D-bagged systems (e.g., Pall’s Allegro STR) and integrated sensor technologies for real-time monitoring enhance efficiency. Furthermore, the development of high-performance films, such as EVOH-based barrier layers, extends product shelf life, making bioprocess containers viable for long-term storage applications.

Moreover, sustainability concerns and supply chain resilience are influencing adoption. While single-use plastics face environmental scrutiny, manufacturers are investing in recyclable and biodegradable materials, such as Saint-Gobain’s cyclic olefin polymer films. Besides, the pandemic exposed vulnerabilities in global supply chains, prompting companies to adopt modular, disposable solutions that reduce dependency on sterilization and cleaning logistics.

Bioprocess Containers Market Report Highlights

• Based on product, the 2D bioprocess containers segment accounted for the largest share of over 47.0% of the market in 2024.
• The 3D bioprocess containers segment is expected to grow at the fastest CAGR of 23.6% during the forecast period.
• Based on application, the upstream processes segment accounted for the largest share of over 57.0% of the market in 2024 and is projected to grow at the fastest CAGR of 23.3% during the forecast period.
• Based on end use, the pharmaceutical and biopharmaceutical companies segment dominated the bioprocess containers market in 2024, accounting for the largest revenue share of over 60.0%.
• The CROs and CMOs segment is expected to grow at the fastest CAGR of 23.3% over the forecast period.
• Asia Pacific dominated the regional space of the market by registering the largest revenue share of over 36.0% in 2024 and is projected to grow at the fastest CAGR of 23.3% over the forecast period.